Breadcrumb
NIH Guide: Weekly Index for May 29, 2020
Weekly NIH Funding Opportunities and Notices
May 29, 2020
Policy Notices
-
RESCINDED - The Agency for Healthcare Research and Quality Data Management Plan Policy
(NOT-HS-20-011)Agency for Healthcare Research and Quality
General Notices
-
NIAID Late Application Policy for NIAID-Specific RFAs with Due Dates in June 2020
(NOT-AI-20-053)National Institute of Allergy and Infectious Diseases
-
NHLBI Announces Availability of Frequently Asked Questions (FAQs) for PAR-19-328: Single-Site Investigator-Initiated Clinical Trials (R61/R33 Clinical Trial Required)
(NOT-HL-20-791)National Heart, Lung, and Blood Institute
-
Request for Information (RFI): Input on data sources and data science questions to advance research on alcohol use
(NOT-AA-20-013)National Institute on Alcohol Abuse and Alcoholism
-
Request for Information (RFI): Input to Enhance the Impact of the NCI Experimental Therapeutics Programs Chemical Biology Consortium on Cancer Drug Discovery and Development
(NOT-CA-20-071)National Cancer Institute
Notice of Changes to Funding Opportunities
-
Notice of NCI's Participation in PA-20-201, "Mentored Clinical Scientist Research Career Development Award (Parent K08 Independent Basic Experimental Studies with Humans Required)
(NOT-CA-20-070)National Cancer Institute
-
NCI Late Application Policy for NCI-Specific RFAs with Application Due Date of June 24, 2020
(NOT-CA-20-072)National Cancer Institute
-
Notice of Early Expiration of Notice of Special Interest (NOSI): Administrative Supplements to Existing R01 Grants on Polycystic Kidney Disease (PKD)
(NOT-DK-20-032)National Institute of Diabetes and Digestive and Kidney Diseases
-
Notice of Change in Application Due Date for RFA-HL-19-015 "Physician-Scientist (PS) Research Awardfor Early Stage Investigators (ESIs) (R01 - Clinical Trial Optional)"
(NOT-HL-20-793)National Heart, Lung, and Blood Institute
-
Notice to Extend RFA-MH-20-510, "Laboratories to Optimize Digital Health (R01 Clinical Trial Required)"
(NOT-MH-20-054)National Institute of Mental Health
-
Notice of Change to Budget for PAR-18-833, Developmental AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optional)
(NOT-MH-20-056)National Institute of Mental Health
-
Notice of Change to Budget for PAR-18-832 AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optional)
(NOT-MH-20-057)National Institute of Mental Health
-
Notice of Change to Eligible Activity Codes for NOT-NS-20-051 "Notice of Special Interest: Availability of Urgent Competitive Revisions and Administrative Supplements For Research on Biological Effects of the 2019 Novel Coronavirus on the Nervous System"
(NOT-NS-20-074)National Institute of Neurological Disorders and Stroke
Notices of Intent to Publish
-
Notice of Intent to Publish Funding Opportunity Announcements for the RADx-UP Initiatives
(NOT-OD-20-112)National Institutes of Health
Notices of Special Interest
-
Notice of Special Interest: Dementia Care Workforce for Those Living with Alzheimers Disease and Alzheimers Disease-Related Dementias (AD/ADRD)
(NOT-AG-20-026)National Institute on Aging
-
Notice of Special Interest (NOSI): Availability of Administrative Supplements & Urgent Competitive Revisions to NCCIH Grants for Natural Product Research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) & Coronavirus Disease 2019 (COVID-19)
(NOT-AT-20-012)National Center for Complementary and Integrative Health
-
Notice of Special Interest (NOSI): Administrative Supplements to Existing R01 Grants on Polycystic Kidney Disease (PKD)
(NOT-DK-20-033)National Institute of Diabetes and Digestive and Kidney Diseases
-
Notice of Special Interest: Promoting Fundamental and Applied Research in Inflammation Resolution
(NOT-ES-20-018)National Institute of Environmental Health SciencesNational Institute of Arthritis and Musculoskeletal and Skin DiseasesNational Heart, Lung, and Blood Institute
-
Notice of Special Interest (NOSI): Administrative Supplements to Existing NIH ECHO Cooperative Agreements (Admin Supp - Clinical Trial Not Allowed) for Coronavirus Disease 2019 (COVID-19) related Research
(NOT-OD-20-107)National Institutes of Health
Funding Opportunities
-
Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed)
(PA-20-222)National Institutes of HealthNational Institute on Alcohol Abuse and AlcoholismNational Institute on AgingNational Institute of Arthritis and Musculoskeletal and Skin DiseasesNational Institute of General Medical SciencesNational Cancer InstituteNational Institute on Drug AbuseNational Institute on Deafness and Other Communication DisordersNational Institute of Dental and Craniofacial ResearchNational Institute of Diabetes and Digestive and Kidney DiseasesNational Institute of Environmental Health SciencesNational Eye InstituteEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentNational Human Genome Research InstituteNational Heart, Lung, and Blood InstituteNational Library of MedicineNational Institute of Mental HealthNational Institute of Nursing ResearchNational Institute of Neurological Disorders and StrokeNational Center for Advancing Translational SciencesJohn E. Fogarty International CenterNational Center for Complementary and Integrative HealthNational Institute of Biomedical Imaging and BioengineeringNational Institute for Occupational Safety and HealthNational Institute on Minority Health and Health DisparitiesNational Center for Advancing Translational SciencesDivision of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure ProgramsApplication Receipt Date(s): Due dates vary by awarding IC Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Limited Competition: National Primate Research Centers (P51) Program
(PAR-20-181)Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure ProgramsApplication Receipt Date(s): Standard dates apply. The first standard application due date for this FOA is September 25, 2020. All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Institutional Network Award for Promoting Kidney, Urologic, and Hematologic Research Training (U2C/TL1 - Clinical Trial Not Allowed)
(PAR-20-220)National Institute of Diabetes and Digestive and Kidney DiseasesApplication Receipt Date(s): September 28, 2020, September 28, 2021, September 28, 2022 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Development of Cost-Effective and Customizable Training and Education Platforms for AD/ADRD Caregivers that Focus on Addressing Financial Management and Legal Planning (R43/R44 Clinical Trial Not Allowed)
(RFA-AG-21-025)National Institute on AgingApplication Receipt Date(s): November 12, 2020
-
Collaborative Pediatric Critical Care Research Network (PL1 Clinical Trial Required)
(RFA-HD-21-016)Eunice Kennedy Shriver National Institute of Child Health and Human DevelopmentApplication Receipt Date(s): July 30, 2020 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. No late applications will be accepted for this Funding Opportunity Announcement.
NIH Funding Opportunities are also available in an RSS feed (Really Simple Syndication).
Subscribe/Unsubscribe from the NIH Guide Weekly TOC LISTSERV.
For technical issues E-mail OER Webmaster